In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pharming Group N.V.

http://www.pharming.com

Latest From Pharming Group N.V.

Industry Leaderboard Gains And Dips Were Still Marked By COVID-19

Pfizer held the number one spot on the Scrip 100 on the strength of its COVID-19 products, while some others faced challenging financial comparisons in 2022 because of COVID-19 headwinds.

Outlook 2024 Commercial Strategies

Big Pharma Shouts, Generics And Biosimilars Whisper: M&A In 2023

“A lot of companies are hurting because of the higher interest rates,” one major CEO observed recently, summing up a year which saw little headline-grabbing news on the M&A front for generic and biosimilar sponsors.

C-Suite Speaks Commercial Strategies

BioCardia Aims To Defy Precedent With A Cardiac Cell Therapy

Heart disease seems impervious to cell therapy approaches. Is biomarker stratification the answer?

Clinical Trials Cardiovascular

BMS Spends $100m On Orum’s Antibody-Guided Protein Degrader

ORM-6151 combines two hot approaches in cancer R&D, but clinical trials have not yet started.

Deals Companies
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Biotechnology
    • Drug Discovery Tools
    • Large Molecule
    • Synthesis Technologies, Production Processes
    • Transgenics
    • Drug Discovery Tools
      • Genomics-Proteomics
UsernamePublicRestriction

Register